News

Mindray Medical International, a developer, manufacturer and marketer of medical devices, has reported that GAAP net income was $31.6m, or $0.28 per diluted share, for the fourth quarter

MedX Health, a developer of drug free, non-invasive low level laser and light therapy for tissue repair and pain relief, has received the CE Mark approval to market

pSivida, a drug delivery company, has completed enrollment of the BrachySil dose ranging clinical trial. The dose ranging study, conducted in the UK at Guy’s and St Thomas’

Quarter 4 2008 Results Revenues for quarter 4, 2008 amounted to $34.0 million compared to $35.7m for quarter 4, 2007, a decrease of 4.8%. This included a decrease

Anacor Pharmaceuticals, a biopharmaceutical company, has announced positive results from a Phase I clinical trial of AN2718, an investigational topical anti-fungal product candidate for the potential treatment of

John Brown is a PhD pharmacologist who has considerable management experience in the healthcare sector, most recently as chief executive officer of Acambis plc until 2004. Since that

Diamyd Medical, a biopharmaceutical company, has announced that the Swedish Medical Products Agency has approved a study with the Diamyd diabetes vaccine in children with high risk to

Cordex Pharma, a developer of cardiovascular medicines, has filed a formulation patent covering its lead product, ATPace. ATPace is a stable liquid formulation of adenosine triposphate (ATP) for

Anika Therapeutics, a developer and marketer of therapeutic products for tissue protection, healing and repair, has reported net income of $1.09m or $0.10 per diluted share for the